SCHEMBL76419

SCHEMBL76419

N#CC1COc2cc[c]cc2O1

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CD274 Q9NZQ7 1/20 0.34
LTA4H P09960 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL76420 0.93 CD274 (0.32) CD274LTA4H
SCHEMBL706276 0.78 NISCH (0.44) LTA4H
SCHEMBL9380529 0.74
SCHEMBL1450868 0.71 HTT (0.39)
SCHEMBL22636270 0.71 LMNA (0.43) CD274
SCHEMBL6675917 0.71 CHRNB4 (0.39)
SCHEMBL6374553 0.70 NISCH (0.45)
SCHEMBL9685921 0.69 CHRNB4 (0.49)
SCHEMBL14810951 0.69 ITGB2 (0.30)
SCHEMBL25370068 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129160-B2 Method of screening for inhibitors of glutaminyl cyclase activity PROBIODRUG AG (DE) 2012-03-06 US disclosed
EP-1773831-A1 ANTIBACTERIAL AGENTS GLAXO GROUP LIMITED (GB) 2007-04-18 EP disclosed
WO-2006014580-A1 ANTIBACTERIAL AGENTS GLAXO GROUP LIMITED (GB) 2006-02-09 WO disclosed